DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Status of Claims
The arguments filed on 08/14/2026 are acknowledged and have been fully considered. Claims 1-4 and 13-16 are now pending. Claim 1 is amended; claims 5-12 are cancelled.
Claims 1-4 and 13-16 will be examined on the merits herein.
Objections/Rejections Withdrawn
Rejections and/or objections not reiterated from previous Office Actions are hereby withdrawn. The following rejections and/or objections are either reiterated or newly applied, and constitute the complete set presently being applied to the instant application.
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
Claims 1-4 and 13-16 are rejected under 35 U.S.C. 103 as being unpatentable over CA 2008143 A1 (Perner, 1990) in view of Champion (2007).
In regards to claim 1, Perner teaches a method of making a solution of polyglycerol maleate (see Perner, examples 1-3).
Perner is silent on the poly(glycerol maleate) being in the form of microparticles but does disclose spray drying the product in the examples (such as example 5).
In regards to claims 1-4 and 13-16, Champion teaches a method of drying polymer solutions, such as spray drying, to form spherical polymer micro- and nano- particles for use as drug carriers (i.e. a product) (see Champion, title, figures and paragraph bridging pages 1-2). As the solution is dried into particles, using the broadest reasonable interpretation, that these particles would be solid (i.e. having a solid structure). However, it is also noted that Champion teaches methods that product non-spherical solid particles as well (see Champion, page 3, paragraph 4).
Further in regards to the particle size limitation of the instant claims, Champion teaches that the particle size influences almost every aspect of particle function including degradation, flow properties, clearance and uptake mechanisms. It is noted that this is within a discussion of the importance of particle size and how it affects the degradation of the particles. As such, one with ordinary skill in the art reading Champion would understand that the particle size would have been considered a result effective variable by one having ordinary skill in the art before the effective filing date of the invention. As such, without showing unexpected results, the claimed particle size cannot be considered critical. Accordingly, one of ordinary skill in the art before the effective filing date of the invention would have optimized, by routine experimentation, the particle size in Champion to obtain the desired balance between the degradability as taught by Champion (In re Boesch, 617 F.2d. 272, 205 USPQ 215 (CCPA 1980)), since it has been held that where the general conditions of the claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine skill in the art. (In re Aller, 105 USPQ 223). “[W]here the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation.” See In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955). The discovery of an optimum value of a known result effective variable, without producing any new or unexpected results, is within the ambit of a person of ordinary skill in the art. See In re Boesch, 205 USPQ 215 (CCPA 1980) (see MPEP § 2144.05, II.).
In regards to claims 1-4 and 13-16, it would have been prima facie obvious to a person of ordinary skill in the art, before the effective filing date of the claimed invention, to formulate a composition as instant claimed using the teachings of Perner and Champion as the methods of Champion are directed toward making polymer based microparticles and Perner is directed towards a polymer solution. Further, it is specifically taught that the polyglycerol aminocarboxylate that is formed by esterification using maleic anhydride (i.e. polyglycerol maleate) is known to have very good biodegrability (see Perner, page 4, lines 26-32). One with ordinary skill in the art would be motivated to combine the polyglycerol maleate solution of Perner with the teachings of Champion according to the method of forming microparticles (see Champion, paragraph bridging pages 1-2) to yield predictable results with a reasonable expectation of success. One with ordinary skill in the art would be motivated to combine prior art elements according to known methods to yield predictable results.
Further in regards to claims 1-2 and 13-14, specifically to the teaching of the polydispersity index and the degradability of the microparticle, as the combination of teachings of Perner and Champion renders it obvious to arrive at the composition instantly claimed. As the combined teachings of the prior art arrives at the composition as claimed, the properties applicant discloses and/or claims would necessarily follow absent evidence to the contrary.
Response to Arguments
Applicant's arguments filed 08/14/2026 have been fully considered but they are not persuasive.
First, examiner thanks Dr. Jane Wang for the declaration filed under 37 CFR 1.132. However as discussed below, it is not enough to establish unexpected results in order to overcome the rejection of record.
In regards to applicant’s arguments that the art does not teach the newly amended claimed range of grain size and the declaration of Dr. Jane Wang, it is noted that the prior art does not teach the claimed range. However, it is also pointed out that one with ordinary skill in the art reading Champion would understand that the particle size would have been considered a result effective variable by one having ordinary skill in the art before the effective filing date of the invention. As such, without showing unexpected results, the claimed particle size cannot be considered critical. Accordingly, one of ordinary skill in the art before the effective filing date of the invention would have optimized, by routine experimentation, the particle size in Champion to obtain the desired balance between the degradability as taught by Champion (In re Boesch, 617 F.2d. 272, 205 USPQ 215 (CCPA 1980)), since it has been held that where the general conditions of the claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine skill in the art. (In re Aller, 105 USPQ 223). “[W]here the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation.” See In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955). The discovery of an optimum value of a known result effective variable, without producing any new or unexpected results, is within the ambit of a person of ordinary skill in the art. See In re Boesch, 205 USPQ 215 (CCPA 1980) (see MPEP § 2144.05, II.). In order to overcome this, applicant has presented data in the form of a declaration, which is appreciated. It is noted that there is a difference between the mechanical strength of the larger particle sizes when compared to the smaller sizes. Unfortunately, the data presented is still not enough to establish unexpected results. First, it is noted that the data is drawn to mechanical properties of particles of different sizes, however the specification nor disclosure overall provide any connection between these mechanical properties and degradability as claimed. Second, the grain sizes used in the data are close to the claimed lower and upper sizes however this is not enough to establish the criticality of the range. To establish unexpected results over a claimed range, applicants should compare a sufficient number of tests both inside and outside the claimed range to show the criticality of the claimed range. In re Hill, 284 F.2d 955, 128 USPQ 197 (CCPA 1960). In this case, 38µm and 105µm are far from the end points of the range and there is no example given where the size of the particle is less than the claimed range either. Finally, even with if degradability was linked to the mechanical properties as shown in the declaration, the claims are drawn to the particles being degraded in a medium (i.e., seawater, freshwater, or an aqueous solution with a pH value of greater than or equal to 4 and less than or equal to 10), but no medium is discussed for the data shown. As such, the data shown is not commensurate with the scope of the claims in this case. Applicant is reminded that whether the unexpected results are the result of unexpectedly improved results or a property not taught by the prior art, the "objective evidence of nonobviousness must be commensurate in scope with the claims which the evidence is offered to support." In other words, the showing of unexpected results must be reviewed to see if the results occur over the entire claimed range. In re Clemens, 622 F.2d 1029, 1036, 206 USPQ 289, 296 (CCPA 1980).
In regards to applicant’s argument that Champion does not mention, teach, or imply the influence of the particle size on its mechanical strength. It is noted that the claims are not drawn to the mechanical strength of the microparticles either, only that they consist of PGM – a requirement that is met by the prior art. Champion does give other motivation to one with ordinary skill in the art to modify the particle size of the microparticles. The fact that applicant has recognized another advantage which would flow naturally from following the suggestion of the prior art cannot be the basis for patentability when the differences would otherwise be obvious. See Ex parte Obiaya, 227 USPQ 58, 60 (Bd. Pat. App. & Inter. 1985).
Conclusion
No claims allowed.
THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to AYAAN A ALAM whose telephone number is (571)270-1213. The examiner can normally be reached M-F 8-5 EST.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Bethany Barham can be reached at 571-272-6175. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/ISIS A GHALI/Primary Examiner, Art Unit 1611
/A.A.A./Examiner, Art Unit 1611